Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer

Update Il y a 4 ans
Reference: NCT01303029

Woman and Man

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of the study is to evaluate the efficacy of the combination of gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in patients with metastatic pancreatic cancer.


Inclusion criteria

  • Metastatic Pancreatic Cancer

Links